Mr. Hughes is a Managing Director of P&M Corporate Finance and leads the firm’s Medical Technology team. He has over 10 years of business and transaction advisory experience, specializing in assisting clients with mergers and acquisitions, leveraged buyouts, private placements, financings, valuation and strategic consulting. Bryan’s clients have ranged from global life sciences companies to small, privately held businesses. In addition to leading the firm’s Medical Technology team, he has also completed transactions in business services, consumer and industrial sectors.
Mr. Hughes earned a B.B.A. with emphasis in finance from the Stephen M. Ross School of Business at the University of Michigan. He is a licensed securities representative, holding Series 7 and 63 registrations. He has written numerous articles and is a frequent speaker on healthcare investment banking topics.
Transactions
has been acquired by
a portfolio company of
a portfolio company of
has been acquired by
has been acquired by
a portfolio company of
a business unit of
has been acquired by
a portfolio company of
has acquired certain assets of
has sold
to
have been acquired by
has been acquired by
has acquired
has acquired
completed the private placement of $30,500,000 convertible preferred equity with Pharos Capital Group, LLC, Highlander Partners, LP, Hopewell Ventures, and River Cities Capital Funds
has divested its
implant product line to
a Healthpoint Capital Company
has acquired microneedle technology from
has licensed its corplex technology for certain applications to
has acquired a majority equity interest in
has acquired the medical product business of
and
have been acquired by
has sold an equity interest to
has acquired
